Kyntra Bio (KYNB) Inventory Average (2019 - 2026)
Kyntra Bio (KYNB) posted Inventory Average of $3.6 million for Q1 2026, down 6.31% sequentially from $3.8 million in Q4 2025, and up 12.95% YoY from $3.2 million in Q1 2025.
Kyntra Bio (KYNB) Inventory Average (2019 - 2026) Analysis & Trends
Kyntra Bio has reported Inventory Average for 8 years, with the latest figure at $3.6 million in Q1 2026.
- Quarterly Inventory Average rose 12.95% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 12.95% YoY) and the FY2025 annual result came in at $3.4 million, down 66.07% from the prior year.
- Inventory Average retreated to $3.6 million in Q1 2026 per KYNB's latest filing, from $3.8 million in the prior quarter.
- Over five years, Inventory Average peaked at $42.0 million in Q2 2022 and troughed at $3.2 million in Q1 2025.
- A 5-year average of $24.6 million and a median of $26.4 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average surged 98.64% in 2022, then sank 86.69% in 2025.
- Over 5 years, Inventory Average stood at $40.2 million in 2022, then slipped by 28.01% to $28.9 million in 2023, then sank by 53.18% to $13.5 million in 2024, then slumped by 71.92% to $3.8 million in 2025, then fell by 6.31% to $3.6 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $3.6 million, $3.8 million, and $3.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 90.57 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | 196.36 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 137.65 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | - |
| 10 | Kyntra Bio | 30.16 Mn | 30.16 Mn | 1.47 Mn | 3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 3.51 Mn |
| Mar 31, 2025 | 3.16 Mn |
| Dec 31, 2024 | 13.55 Mn |
| Sep 30, 2024 | 24.67 Mn |
| Jun 30, 2024 | 26.37 Mn |
| Mar 31, 2024 | 22.25 Mn |
| Dec 31, 2023 | 28.93 Mn |
| Sep 30, 2023 | 40.94 Mn |
| Jun 30, 2023 | 41.82 Mn |
| Mar 31, 2023 | 41.45 Mn |
| Dec 31, 2022 | 40.19 Mn |
| Sep 30, 2022 | 40.42 Mn |
| Jun 30, 2022 | 41.98 Mn |
| Mar 31, 2022 | 37.04 Mn |
| Dec 31, 2021 | 30.17 Mn |
| Sep 30, 2021 | 26.92 Mn |